UPDATE 1-Eli Lilly considers sale of off-patent drug assets in China - Bloomberg
November 16, 2018 at 08:56 AM EST
Eli Lilly and Co is considering the sale of an off-patent drugs portfolio in China, Bloomberg reported on Friday, citing sources.